Bio-Bridge Science has one month to close the transaction, and obtain the new business license. The transaction is expected to close before the end of July 2008.
Liang Qiao, chairman and CEO of Bio-Bridge, said: “We are happy to see the Inner Mongolia government has approved our acquisition of Xinheng Baide. The completion of the acquisition of Xinheng Baide will be a significant first step of our acquisition strategy. We believe Xinheng Baide will provide revenues and complementary products to Bio-Bridge.”